A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test
NCT00763204
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
AN2728 Cream, 2%
DRUG:
AN2728 Cream, 1%
DRUG:
AN2728 Cream, 0.3%
DRUG:
AN2728 Cream Vehicle
DRUG:
Betnesol®-V Creme, 0.1%
Sponsor
Pfizer